We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

This study is currently recruiting participants.
Verified July 2017 by Theodore Sunki Hong, Massachusetts General Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT01821729
First Posted: April 1, 2013
Last Update Posted: July 26, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Theodore Sunki Hong, Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)